Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-03-22 Sale | 2024-03-22 4:51 pm | CymaBay Therapeutics Inc. | CBAY | EMSTER KURT VON Director | 90,000 | $0 | $0 | 0 (Direct) | View |
| 2023-09-29 Sale | 2023-09-29 5:54 pm | CymaBay Therapeutics Inc. | CBAY | EMSTER KURT VON Director | 15,921 | $15.68 | $249,675 | 108,406 (Indirect Direct) | View |
| 2023-04-13 Sale | 2023-04-14 4:19 pm | Jasper Therapeutics Inc. | JSPR | EMSTER KURT VON Director | 9,075 | $1.4903 | $13,524 | 21,175 (Direct) | View |
| 2021-05-17 Purchase | 2021-05-18 8:10 pm | Vera Therapeutics Inc. | VERA | EMSTER KURT VON Director | 790,555 | $11.02 | $8,714,653 | 2,978,059 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-07-03 Option Award | 2025-07-03 4:24 pm | 2026-07-03 2035-07-03 | Jasper Therapeutics Inc. | JSPR | EMSTER KURT VON Director | 7,500 | $0 | 7,500 (Direct) | View |
| 2024-06-06 Option Award | 2024-06-10 6:15 pm | 2025-06-06 2034-06-06 | Jasper Therapeutics Inc. | JSPR | EMSTER KURT VON Director | 7,500 | $0 | 7,500 (Direct) | View |
| 2024-01-24 Option Award | 2024-01-26 6:10 pm | N/A 2034-01-23 | CymaBay Therapeutics Inc. | CBAY | EMSTER KURT VON Director | 14,010 | $0 | 14,010 (Direct) | View |
| 2023-09-29 Exercise | 2023-09-29 5:54 pm | N/A N/A | CymaBay Therapeutics Inc. | CBAY | EMSTER KURT VON Director | 15,921 | $5 | 108,406 (Direct) | View |
| 2023-09-29 Exercise | 2023-09-29 5:54 pm | N/A 2023-10-30 | CymaBay Therapeutics Inc. | CBAY | EMSTER KURT VON Director | 15,921 | $0 | 108,406 (Direct) | View |
| 2023-06-07 Option Award | 2023-06-08 6:43 pm | 2024-06-07 2033-06-07 | Jasper Therapeutics Inc. | JSPR | EMSTER KURT VON Director | 47,000 | $0 | 47,000 (Direct) | View |
| 2023-01-25 Option Award | 2023-01-27 4:34 pm | N/A 2033-01-24 | CymaBay Therapeutics Inc. | CBAY | EMSTER KURT VON Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2022-10-12 Option Award | 2022-10-13 8:05 pm | N/A N/A | Jasper Therapeutics Inc. | JSPR | EMSTER KURT VON Director | 30,250 | $0 | 30,250 (Direct) | View |
| 2022-03-21 Option Award | 2022-03-23 6:04 pm | N/A 2032-03-21 | Jasper Therapeutics Inc. | JSPR | EMSTER KURT VON Director 10% Owner | 78,045 | $0 | 78,045 (Direct) | View |
| 2022-01-25 Option Award | 2022-01-27 4:53 pm | N/A 2032-01-24 | CymaBay Therapeutics Inc. | CBAY | EMSTER KURT VON Director | 67,000 | $0 | 67,000 (Direct) | View |
Ownership | 2021-10-01 4:12 pm | N/A N/A | Jasper Therapeutics Inc. | JSPR | EMSTER KURT VON Director 10% Owner | 0 | $0 | 5,628,558 (Indirect) | View |
| 2021-06-02 Option Award | 2021-06-03 7:44 pm | N/A 2031-06-01 | Vaxcyte Inc. | PCVX | EMSTER KURT VON Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2021-05-18 Conversion | 2021-05-18 8:10 pm | N/A N/A | Vera Therapeutics Inc. | VERA | EMSTER KURT VON Director | 2,187,504 | $0 | 2,978,059 (Indirect) | View |
| 2021-05-13 Option Award | 2021-05-17 8:34 pm | N/A 2031-05-12 | Vera Therapeutics Inc. | VERA | EMSTER KURT VON Director 10% Owner | 9,925 | $0 | 9,925 (Direct) | View |
Ownership | 2021-05-13 7:13 pm | N/A N/A | Vera Therapeutics Inc. | VERA | EMSTER KURT VON Director 10% Owner | 0 | $0 | 2,187,504 (Indirect) | View |
| 2021-01-26 Option Award | 2021-02-01 7:15 pm | N/A 2031-01-25 | CymaBay Therapeutics Inc. | CBAY | EMSTER KURT VON Director | 32,000 | $0 | 32,000 (Direct) | View |